ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Tofacitinib Impurity 6
Tofacitinib Impurity 6
- CAS No.
- 1640972-35-5
- Chemical Name:
- Tofacitinib Impurity 6
- Synonyms
- Tofacitinib-21;Tofatinib Impurity N;5,6-Dihydro CP-690550;5,6-Dihydro Tofacitinib;Tofacitinib Impurity 39;Tofacitinib Dihydro Imp;Flubendazole Impurity 16;Tofacitinib Related Compound 21;N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amine;(3R,4R)-3-[(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile
- CBNumber:
- CB93133441
- Molecular Formula:
- C16H22N6O
- Molecular Weight:
- 314.39
- MOL File:
- 1640972-35-5.mol
- Modify Date:
- 2024/5/20 14:01:34
Tofacitinib Impurity 6 Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 57)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Molsyns Research | +91-9586858886 +91-9586858886 | Gujarat, India | 418 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
career henan chemical co | +86-0371-86658258 +8613203830695 | China | 29826 | 58 | Inquiry |
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | China | 23556 | 58 | Inquiry |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
ShenZhen H&D Pharmaceutical Technology Co., LTD | +86-0755-22677845 +86-13627253706 | China | 3013 | 58 | Inquiry |
Suzhou ARTK Medchem Co., Ltd. | +8618168183658 | China | 39009 | 58 | Inquiry |
Molcoo Chemicals Inc. | 18627923403 18627753421 | China | 9188 | 58 | Inquiry |
1640972-35-5(Tofacitinib Impurity 6)Related Search:
Tofacitinib related coMpound 2
3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 2
Tofacitinib Impurity 3
3-Amino-4-methylpyridine
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate
13-Deoxyepirubicin
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-METHOXYCARBONYLAMINO-4-METHYLPYRIDINE
1-[2-(2-methoxyphenoxy)ethylamino]-3-(9-methylcarbazol-4-yl)oxypropan-2-ol:hydrochloride
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
Methyl (4-Methylpiperidin-3-yl)carbaMate
chevron_left
1of4
chevron_right
Tofacitinib Impurity 39
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amine
Tofacitinib-21
Tofacitinib impurity 14/5,6-Dihydro Tofacitinib/3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
Tofacitinib impurity 15/5,6-Dihydro Tofacitinib Citrate/3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
5,6-Dihydro CP-690550
3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Related Compound 21
(3R,4R)-3-[(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile
1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-
5,6-Dihydro Tofacitinib
(3R,4R)-3-[(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile
Tofatinib Impurity N
Flubendazole Impurity 16
Tofacitinib Dihydro Imp
1640972-35-5